Loading...

Rosa Rodriguez-Monguio, MS, PhD

Title(s)Professor, Clinical Pharmacy
SchoolSchool of Pharmacy
Phone415-502-6029
EmailRosa.Rodriguez-Monguio@ucsf.edu
ORCID ORCID Icon0000-0002-5526-9395 Additional info
vCardDownload vCard
    Other Positions
    Title(s)Director, Medication Outcomes Center


    Collapse Biography 
    Collapse Education and Training
    PhD2001Health Economics
    MS2016Clinical Research
    Collapse Awards and Honors
    UCSF, School of Pharmacy2019Dean’s Apple Award

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Shortages of Opioid Analgesics: Safety and Treatment Cost Implications in Surgical Patients
    CTSI-Pilot Awards RAS A127552Jun 1, 2019 - May 31, 2020
    Role: PI
    Impact of Drug Shortages on Patient Care and Treatment Cost
    University of California Strategic Initiative Funds A2015640Jul 1, 2018 - Jun 30, 2020
    Role: PI

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Shukla V, Seoane E, Souhiela F, Lawrence B, Rodriguez-Monguio R.The Landscape of Cellular and Gene Therapy Products: Cost, Approvals, and Discontinuations. Hum Gene Ther Clin Dev. 2019 Sep;30(3):102-113. doi: 10.1089/humc.2018.201. Epub 2019 Jul 16. 2019.
    2. Seoane-Vazquez E, Shukla V, Rodriguez-Monguio R. Innovation and competition in advanced therapy medicinal products. EMBO Mol Med. 2019 Mar; 11(3). PMID: 30770338.
      View in: PubMed
    3. Brand E, Rodriguez-Monguio R, Volber R. Gender differences in mental health and substance use disorders and related healthcare services utilization. Am J Addict. 2019 Jan; 28(1):9-15. PMID: 30536669.
      View in: PubMed
    4. Kron K, Myers S, Volk L, Nathan A, Neri P, Salazar A, Amato MG, Wright A, Karmiy S, McCord S, Seoane-Vazquez E, Eguale T, Rodriguez-Monguio R, Bates DW, Schiff G. Incorporating medication indications into the prescribing process. Am J Health Syst Pharm. 2018 06 01; 75(11):774-783. PMID: 29674327.
      View in: PubMed
    5. Whitehill JM, Rodriguez-Monguio R, Doucette M, Flom E. Driving and riding under the influence of recent marijuana use: Risk factors among a racially diverse sample of young adults. J Ethn Subst Abuse. 2018 Feb 12; 1-19. PMID: 29432083.
      View in: PubMed
    6. Kwon CS, Seoane-Vazquez E, Rodriguez-Monguio R. Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetes. BMC Health Serv Res. 2018 02 01; 18(1):78. PMID: 29391064.
      View in: PubMed
    7. Rodriguez-Monguio R, Brand E, Volberg R. The Economic Burden of Pathological Gambling and Co-occurring Mental Health and Substance Use Disorders. J Addict Med. 2018 Jan/Feb; 12(1):53-60. PMID: 29068825.
      View in: PubMed
    8. Balkhi B, Seoane-Vazquez E, Rodriguez-Monguio R. Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication. Saudi Pharm J. 2018 Feb; 26(2):238-243. PMID: 30166922.
      View in: PubMed
    9. Bowdoin JJ, Rodriguez-Monguio R, Puleo E, Keller D, Roche J. The patient-centered medical home model: healthcare services utilization and cost for non-elderly adults with mental illness. J Ment Health. 2018 Dec; 27(6):574-582. PMID: 28990831.
      View in: PubMed
    10. Rodriguez-Monguio R, Errea M, Volberg R. Comorbid pathological gambling, mental health, and substance use disorders: Health-care services provision by clinician specialty. J Behav Addict. 2017 Sep 01; 6(3):406-415. PMID: 28856904.
      View in: PubMed
    11. Seoane-Vazquez E, Rodriguez-Monguio R, Alqahtani S, Schiff G. Exploring the potential for using drug indications to prevent look-alike and sound-alike drug errors. Expert Opin Drug Saf. 2017 Oct; 16(10):1103-1109. PMID: 28724335.
      View in: PubMed
    12. Qureshi ZP, Haider MR, Rodriguez-Monguio R, Wooten NR, Nikitin RV, Ball S, Barth K, Elk R, Horner R, Bennett C. Opioid Prescription Drug Use and Expenditures in US Outpatient Physician Offices: Evidence from Two Nationally Representative Surveys. Cancer Ther Oncol Int J. 2017; 3(3). PMID: 28845476.
      View in: PubMed
    13. Sawad AB, Seoane-Vazquez E, Rodriguez-Monguio R, Turkistani F. Cost-effectiveness of different strategies for treatment relapsing-remitting multiple sclerosis. J Comp Eff Res. 2017 Mar; 6(2):97-108. PMID: 28118731.
      View in: PubMed
    14. Balkhi B, Seoane-Vazquez E, Rodriguez-Monguio R. OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS. Int J Technol Assess Health Care. 2016 Jan; 32(6):385-392. PMID: 28065194.
      View in: PubMed
    15. Rodriguez-Monguio R, Spargo T, Seoane-Vazquez E. Ethical imperatives of timely access to orphan drugs: is possible to reconcile economic incentives and patients' health needs? Orphanet J Rare Dis. 2017 01 05; 12(1):1. PMID: 28057032.
      View in: PubMed
    16. Bin Sawad A, Seoane-Vazquez E, Rodriguez-Monguio R, Turkistani F. Evaluation of the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite as clinical endpoints in multiple sclerosis clinical trials: quantitative meta-analyses. Curr Med Res Opin. 2016 12; 32(12):1969-1974. PMID: 27603119.
      View in: PubMed
    17. Bowdoin JJ, Rodriguez-Monguio R, Puleo E, Keller D, Roche J. Associations between the patient-centered medical home and preventive care and healthcare quality for non-elderly adults with mental illness: A surveillance study analysis. BMC Health Serv Res. 2016 08 24; 16(1):434. PMID: 27557785.
      View in: PubMed
    18. Bin Sawad A, Seoane-Vazquez E, Rodriguez-Monguio R, Turkistani F. Price analysis of multiple sclerosis disease-modifying therapies marketed in the United States. Curr Med Res Opin. 2016 11; 32(11):1783-1788. PMID: 27359262.
      View in: PubMed
    19. Seoane-Vazquez E, Rodriguez-Monguio R, Alqahtani S. Response to letter to the editor regarding Alqahtani et al. Article on priority review drugs approved by the FDA and the EMA: time for international regulatory harmonization of pharmaceuticals? Pharmacoepidemiol Drug Saf. 2016 06; 25(6):745-6. PMID: 27245860.
      View in: PubMed
    20. Zhang N, Lu SF, Xu B, Wu B, Rodriguez-Monguio R, Gurwitz J. Health Information Technologies: Which Nursing Homes Adopted Them? J Am Med Dir Assoc. 2016 05 01; 17(5):441-7. PMID: 27107160.
      View in: PubMed
    21. Zhang N, Rodriguez-Monguio R, Barenberg A, Gurwitz J. Are Obese Residents More Likely to Be Admitted to Nursing Homes That Have More Deficiencies in Care? J Am Geriatr Soc. 2016 05; 64(5):1085-90. PMID: 27225360.
      View in: PubMed
    22. Seoane-Vazquez E, Rodriguez-Monguio R, Hansen R. Interchangeability, Safety and Efficacy of Modified-Release Drug Formulations in the USA: The Case of Opioid and Other Nervous System Drugs. Clin Drug Investig. 2016 Apr; 36(4):281-92. PMID: 26818406.
      View in: PubMed
    23. Okunna NC, Rodriguez-Monguio R, Smelson DA, Poudel KC, Volberg R. Gambling involvement indicative of underlying behavioral and mental health disorders. Am J Addict. 2016 Mar; 25(2):160-72. PMID: 26871884.
      View in: PubMed
    24. Kwon CS, Seoane-Vazquez E, Rodriguez-Monguio R. FDA safety actions for antidiabetic drugs marketed in the US, 1980-2015. Int J Risk Saf Med. 2016; 28(4):197-211. PMID: 28582876.
      View in: PubMed
    25. Hao J, Rodriguez-Monguio R, Seoane-Vazquez E. Fixed-Dose Combination Drug Approvals, Patents and Market Exclusivities Compared to Single Active Ingredient Pharmaceuticals. PLoS One. 2015; 10(10):e0140708. PMID: 26469277.
      View in: PubMed
    26. Hao J, Rodriguez-Monguio R, Seoane-Vazquez E. Fixed-dose combination and single active ingredient drugs: a comparative cost analysis. Expert Rev Pharmacoecon Outcomes Res. 2016; 16(1):127-34. PMID: 26174631.
      View in: PubMed
    27. Bulzacchelli MT, Sulsky SI, Rodriguez-Monguio R, Karlsson LH, Hill LT. Response to Letter to the Editor: Regarding the Bulzacchelli et al. Article on Injury During U.S. Army Basic Combat Training. Am J Prev Med. 2015 Jul; 49(1):e3-5. PMID: 26094237.
      View in: PubMed
    28. Rodriguez-Monguio R. Capsule commentary on Goetz et al., The effect of charge display on cost of care and physician practice behaviors: a systematic review. J Gen Intern Med. 2015 Jun; 30(6):834. PMID: 25749883.
      View in: PubMed
    29. Alqahtani S, Seoane-Vazquez E, Rodriguez-Monguio R, Eguale T. Priority review drugs approved by the FDA and the EMA: time for international regulatory harmonization of pharmaceuticals? Pharmacoepidemiol Drug Saf. 2015 Jul; 24(7):709-15. PMID: 26013294.
      View in: PubMed
    30. Sulsky SI, Karlsson LH, Bulzacchelli MT, Luippold RS, Rodriguez-Monguio R, Bulathsinhala L, Hill OT. Methodological challenges of using U.S. Army administrative data to identify a cohort of basic combat trainees and descriptive analysis of trends in characteristics that are potential risk factors for training-related injury. Mil Med. 2014 Dec; 179(12):1487-96. PMID: 25469973.
      View in: PubMed
    31. Bulzacchelli MT, Sulsky SI, Rodriguez-Monguio R, Karlsson LH, Hill MO. Injury during U.S. Army basic combat training: a systematic review of risk factor studies. Am J Prev Med. 2014 Dec; 47(6):813-22. PMID: 25455122.
      View in: PubMed
    32. Pellegrini LC, Rodriguez-Monguio R. Medicaid provisions and the US mental health industry composition. J Ment Health. 2014 Dec; 23(6):312-6. PMID: 25180818.
      View in: PubMed
    33. Pellegrini LC, Rodriguez-Monguio R, Qian J. The US healthcare workforce and the labor market effect on healthcare spending and health outcomes. Int J Health Care Finance Econ. 2014 Jun; 14(2):127-41. PMID: 24652416.
      View in: PubMed
    34. Rodriguez-Monguio R, Spielberger K, Seoane-Vazquez E. Examination of risk evaluation and mitigation strategies and drug safety in the US. Res Social Adm Pharm. 2014 Jan-Feb; 10(1):232-8. PMID: 23611865.
      View in: PubMed
    35. Jasinski CF, Rodriguez-Monguio R, Tonyushkina K, Allen H. Healthcare cost of type 1 diabetes mellitus in new-onset children in a hospital compared to an outpatient setting. BMC Pediatr. 2013 Apr 15; 13:55. PMID: 23587308.
      View in: PubMed
    36. Nguyen D, Seoane-Vazquez E, Rodriguez-Monguio R, Montagne M. Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies. BMC Health Serv Res. 2013 Jan 22; 13:27. PMID: 23339419.
      View in: PubMed
    37. Outterson K, Powers JH, Seoane-Vazquez E, Rodriguez-Monguio R, Kesselheim AS. Approval and withdrawal of new antibiotics and other antiinfectives in the U.S., 1980-2009. J Law Med Ethics. 2013; 41(3):688-96. PMID: 24088160.
      View in: PubMed
    38. Zhang H, Rodriguez-Monguio R. Racial disparities in the risk of developing obesity-related diseases: a cross-sectional study. Ethn Dis. 2012; 22(3):308-16. PMID: 22870574.
      View in: PubMed
    39. Visaria J, Seoane-Vazquez E, Szeinbach SL, Rodriguez-Monguio R. Comparing the cost of community pharmacy and mail-order pharmacy in a US retirement system. Int J Health Plann Manage. 2012 Jan-Mar; 27(1):e41-50. PMID: 21638311.
      View in: PubMed
    40. Qureshi ZP, Seoane-Vazquez E, Rodriguez-Monguio R, Stevenson KB, Szeinbach SL. Market withdrawal of new molecular entities approved in the United States from 1980 to 2009. Pharmacoepidemiol Drug Saf. 2011 Jul; 20(7):772-7. PMID: 21574210.
      View in: PubMed
    41. Seoane-Vazquez E, Rodriguez-Monguio R. Access to essential drugs in Guyana: a public health challenge. Int J Health Plann Manage. 2010 Jan-Mar; 25(1):2-16. PMID: 18536003.
      View in: PubMed
    42. Rodriguez-Monguio R, Seoane-Vazquez E. Patent life of antiretroviral drugs approved in the US from 1987 to 2007. AIDS Care. 2009 Jun; 21(6):760-8. PMID: 19499381.
      View in: PubMed
    43. Seoane-Vazquez E, Rodriguez-Monguio R, Szeinbach SL, Beyer A, Visaria J. Analysis of the impact of the Uruguay Round Agreements Act on pharmaceutical patents. Food Drug Law J. 2009; 64(1):171-81. PMID: 19998745.
      View in: PubMed
    44. Seoane-Vazquez E, Rodriguez-Monguio R, Szeinbach SL, Visaria J. Incentives for orphan drug research and development in the United States. Orphanet J Rare Dis. 2008 Dec 16; 3:33. PMID: 19087348.
      View in: PubMed
    45. Seoane-Vazquez E, Rodriguez-Monguio R. Endoscopy-related infection: relic of the past? Curr Opin Infect Dis. 2008 Aug; 21(4):362-6. PMID: 18594287.
      View in: PubMed
    46. Valluri S, Seoane-Vazquez E, Rodriguez-Monguio R, Szeinbach SL. Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy. BMC Health Serv Res. 2007 Jul 30; 7:122. PMID: 17663768.
      View in: PubMed
    47. Seoane-Vazquez E, Rodriguez-Monguio R, Visaria J, Carlson A. Endoscopy-related infections and toxic reactions: an international comparison. Endoscopy. 2007 Aug; 39(8):742-6. PMID: 17583855.
      View in: PubMed
    48. Seoane-Vazquez E, Rodriguez-Monguio R. Negotiating antiretroviral drug prices: the experience of the Andean countries. Health Policy Plan. 2007 Mar; 22(2):63-72. PMID: 17299024.
      View in: PubMed
    49. Seoane-Vazquez E, Rodriguez-Monguio R, Visaria J, Carlson A. Exogenous endoscopy-related infections, pseudo-infections, and toxic reactions: clinical and economic burden. Curr Med Res Opin. 2006 Oct; 22(10):2007-21. PMID: 17022860.
      View in: PubMed
    50. Rodríguez-Monguió R, Rovira J, Seoane-Vázquez E. Analysis of the World Bank's pharmaceutical lending. Health Policy. 2007 Apr; 81(1):102-16. PMID: 16824640.
      View in: PubMed
    51. Rodríguez-Monguió R, Antoñanzas Villar F. Healthcare rationing in Spain: framework, descriptive analysis and consequences. Pharmacoeconomics. 2006; 24(6):537-48. PMID: 16761902.
      View in: PubMed
    52. Rodríguez-Monguió R, Otero MJ, Rovira J. Assessing the economic impact of adverse drug effects. Pharmacoeconomics. 2003; 21(9):623-50. PMID: 12807365.
      View in: PubMed